BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33072574)

  • 1. An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma.
    Kumar V; Ray S; Ghantasala S; Srivastava S
    Front Oncol; 2020; 10():543997. PubMed ID: 33072574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.
    Keshishian H; Burgess MW; Gillette MA; Mertins P; Clauser KR; Mani DR; Kuhn EW; Farrell LA; Gerszten RE; Carr SA
    Mol Cell Proteomics; 2015 Sep; 14(9):2375-93. PubMed ID: 25724909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation.
    Bhosale SD; Moulder R; Kouvonen P; Lahesmaa R; Goodlett DR
    Methods Mol Biol; 2017; 1619():451-466. PubMed ID: 28674903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
    Mermelekas G; Vlahou A; Zoidakis J
    Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry.
    Keshishian H; Burgess MW; Specht H; Wallace L; Clauser KR; Gillette MA; Carr SA
    Nat Protoc; 2017 Aug; 12(8):1683-1701. PubMed ID: 28749931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples.
    Verma A; Kumar V; Ghantasala S; Mukherjee S; Srivastava S
    J Vis Exp; 2021 Nov; (177):. PubMed ID: 34842228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Parallel Reaction Monitoring-Parallel Accumulation-Serial Fragmentation (prm-PASEF) Approach for Multiplexed Absolute Quantitation of Proteins in Human Plasma.
    Brzhozovskiy A; Kononikhin A; Bugrova AE; Kovalev GI; Schmit PO; Kruppa G; Nikolaev EN; Borchers CH
    Anal Chem; 2022 Feb; 94(4):2016-2022. PubMed ID: 35040635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Targeted Mass Spectrometry (Parallel Accumulation-Serial Fragmentation) and Its Application in Plasma/Serum Proteomics.
    Hu A; Zhang J; Shen H
    Methods Mol Biol; 2023; 2628():339-352. PubMed ID: 36781796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Method for Label-Free, Differential Top-Down Proteomics.
    Ntai I; Toby TK; LeDuc RD; Kelleher NL
    Methods Mol Biol; 2016; 1410():121-33. PubMed ID: 26867742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DPHL: A DIA Pan-human Protein Mass Spectrometry Library for Robust Biomarker Discovery.
    Zhu T; Zhu Y; Xuan Y; Gao H; Cai X; Piersma SR; Pham TV; Schelfhorst T; Haas RRGD; Bijnsdorp IV; Sun R; Yue L; Ruan G; Zhang Q; Hu M; Zhou Y; Van Houdt WJ; Le Large TYS; Cloos J; Wojtuszkiewicz A; Koppers-Lalic D; Böttger F; Scheepbouwer C; Brakenhoff RH; van Leenders GJLH; Ijzermans JNM; Martens JWM; Steenbergen RDM; Grieken NC; Selvarajan S; Mantoo S; Lee SS; Yeow SJY; Alkaff SMF; Xiang N; Sun Y; Yi X; Dai S; Liu W; Lu T; Wu Z; Liang X; Wang M; Shao Y; Zheng X; Xu K; Yang Q; Meng Y; Lu C; Zhu J; Zheng J; Wang B; Lou S; Dai Y; Xu C; Yu C; Ying H; Lim TK; Wu J; Gao X; Luan Z; Teng X; Wu P; Huang S; Tao Z; Iyer NG; Zhou S; Shao W; Lam H; Ma D; Ji J; Kon OL; Zheng S; Aebersold R; Jimenez CR; Guo T
    Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):104-119. PubMed ID: 32795611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
    Percy AJ; Chambers AG; Yang J; Borchers CH
    Proteomics; 2013 Jul; 13(14):2202-15. PubMed ID: 23592487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathway-Informed Discovery and Targeted Proteomic Workflows Using Mass Spectrometry.
    Chu CS; Miller CA; Gieschen A; Fischer SM
    Methods Mol Biol; 2017; 1550():199-221. PubMed ID: 28188532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer.
    Li QR; Liu YS; Zeng R
    Methods Mol Biol; 2017; 1619():385-394. PubMed ID: 28674898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
    Russell CL; Heslegrave A; Mitra V; Zetterberg H; Pocock JM; Ward MA; Pike I
    Rapid Commun Mass Spectrom; 2017 Jan; 31(2):153-159. PubMed ID: 27813239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum.
    Chambers AG; Percy AJ; Simon R; Borchers CH
    Expert Rev Proteomics; 2014 Apr; 11(2):137-48. PubMed ID: 24476379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cost-Effective High-Throughput Plasma and Serum Proteomics Workflow Enables Mapping of the Molecular Impact of Total Pancreatectomy with Islet Autotransplantation.
    Bennike TB; Bellin MD; Xuan Y; Stensballe A; Møller FT; Beilman GJ; Levy O; Cruz-Monserrate Z; Andersen V; Steen J; Conwell DL; Steen H
    J Proteome Res; 2018 May; 17(5):1983-1992. PubMed ID: 29641209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
    Núñez Galindo A; Macron C; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Analysis of Tissue Samples by Combining iTRAQ Isobaric Labeling with Selected/Multiple Reaction Monitoring (SRM/MRM).
    Narumi R; Tomonaga T
    Methods Mol Biol; 2016; 1355():85-101. PubMed ID: 26584920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition.
    Vidova V; Spacil Z
    Anal Chim Acta; 2017 Apr; 964():7-23. PubMed ID: 28351641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.